​

Labcorp Holdings Stock (NYSE:LH)

ForecastRevenueOwnershipFinancialsChartTranscripts
Labcorp Holdings by TradingView

Previous Close

$306.96

52W Range

$244.52 - $341.80

50D Avg

$308.97

200D Avg

$276.43

Market Cap

$25.55B

Avg Vol (3M)

$693.12K

Beta

0.85

Div Yield

$2.88 (0.92%)

LH Company Profile

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Show More

Industry

Medical - Diagnostics & Research

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

71,000

IPO Date

Mar 29, 1990

Website

LH Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25Dec 24Dec 22
LabCorp Diagnostics$10.88B$10.14B-
Drug Development--$5.71B
Diagnostics--$9.20B

Fiscal year ends in Dec 25 | Currency in USD

LH Financial Summary

Dec 25Dec 24Dec 23
Revenue$13.95B$13.01B$12.16B
Operating Income$1.52B$1.09B$725.60M
Net Income$876.50M$746.00M$418.00M
EBITDA$2.20B$1.81B$1.35B
Basic EPS$10.54$8.89$4.80
Diluted EPS$10.46$8.84$4.77

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q2 26Jul 30, 26 | 9:00 AM
Q1 26Apr 30, 26 | 9:00 AM
Q4 25Feb 17, 26 | 9:00 AM

Peer Comparison

TickerCompany
WATWaters Corporation
BIIBBiogen Inc.
ILMNIllumina, Inc.
DGXQuest Diagnostics Incorporated
DXCMDexCom, Inc.
WSTWest Pharmaceutical Services, Inc.
ZBHZimmer Biomet Holdings, Inc.
UTHRUnited Therapeutics Corporation
STESTERIS plc
INCYIncyte Corporation